A representative co-staining of IL-17 and IFN-γ within intestinal CD4+ T cells is shown in one IL-21-treated and one control RM at wks-2 (pre-infection), 4 (during the IL-21 treatment) and 23 p.i. (Figure 5C). The gene discussed is IFNG; the disease is infection.